Canaccord Genuity Reiterates a 'Buy' on PhotoMedex (PHMD) After Meeting with Management

June 18, 2012 8:54 AM EDT
Get Alerts PHMD Hot Sheet
Price: $1.07 --0%

Rating Summary:
    2 Buy, 3 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on PhotoMedex (NASDAQ: PHMD) price target of $22.00.

Analyst, William J. Plovanic, said, "While investors were providing lots of advice on how to combat the retreating stock price, we took notice of management’s focus on execution of its business plan. Specifically, we noted that, as projected, PhotoMedex is adding new geographies and products for its no!no! consumer brand. Furthermore, the DTC marketing plan for XTRAC for psoriasis was successful (as noted on the Q1/12 call) and is being expanded nationally. In short, we are more confident that fundamentals of the business are on track and are reiterating our rating and price target."

For an analyst ratings summary and ratings history on PhotoMedex click here. For more ratings news on PhotoMedex click here.

Shares of PhotoMedex closed at $13.56 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments